Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient

We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy. A young male developed secondary ocular hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Rathini Lilian, Sen, Parveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394078/
https://www.ncbi.nlm.nih.gov/pubmed/32792805
http://dx.doi.org/10.4103/ojo.OJO_40_2018
_version_ 1783565163990876160
author David, Rathini Lilian
Sen, Parveen
author_facet David, Rathini Lilian
Sen, Parveen
author_sort David, Rathini Lilian
collection PubMed
description We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy. A young male developed secondary ocular hypertension following dexamethasone implant (OZURDEX) injection for control of posterior uveitis. As the implant was still present in the vitreous cavity, we successfully performed a pars plana removal of the implant along with trabeculectomy with mitomycin C. Early intervention is essential to prevent glaucomatous optic neuropathy in young uveitic patients receiving OZURDEX implant.
format Online
Article
Text
id pubmed-7394078
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-73940782020-08-12 Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient David, Rathini Lilian Sen, Parveen Oman J Ophthalmol Case Report We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy. A young male developed secondary ocular hypertension following dexamethasone implant (OZURDEX) injection for control of posterior uveitis. As the implant was still present in the vitreous cavity, we successfully performed a pars plana removal of the implant along with trabeculectomy with mitomycin C. Early intervention is essential to prevent glaucomatous optic neuropathy in young uveitic patients receiving OZURDEX implant. Wolters Kluwer - Medknow 2020-05-28 /pmc/articles/PMC7394078/ /pubmed/32792805 http://dx.doi.org/10.4103/ojo.OJO_40_2018 Text en Copyright: © 2020 Oman Ophthalmic Society http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
David, Rathini Lilian
Sen, Parveen
Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
title Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
title_full Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
title_fullStr Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
title_full_unstemmed Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
title_short Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
title_sort secondary ocular hypertension post intravitreal dexamethasone implant (ozurdex) managed by pars plana implant removal along with trabeculectomy in a young patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394078/
https://www.ncbi.nlm.nih.gov/pubmed/32792805
http://dx.doi.org/10.4103/ojo.OJO_40_2018
work_keys_str_mv AT davidrathinililian secondaryocularhypertensionpostintravitrealdexamethasoneimplantozurdexmanagedbyparsplanaimplantremovalalongwithtrabeculectomyinayoungpatient
AT senparveen secondaryocularhypertensionpostintravitrealdexamethasoneimplantozurdexmanagedbyparsplanaimplantremovalalongwithtrabeculectomyinayoungpatient

Ejemplares similares